Main content
Why drug firms don鈥檛 invest more in curing early stage cancer
MIT Economics Professor Heidi Williams studied the treatments that got the most funding.
Image: Chemotherapy treatment being prepared at Johns Hopkins Cancer Centre/Getty.
Duration:
This clip is from
More clips from The Inquiry
-
![]()
Ukraine war: How Russia benefits from Europe buying its gas
Duration: 03:47
-
![]()
How the Ukrainian resistance is exposing Russian weakness
Duration: 03:19
-
![]()
West African coups: What comes next?
Duration: 03:23
